InvestorsHub Logo

H2R

Followers 41
Posts 2215
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: None

Friday, 04/15/2016 9:00:58 AM

Friday, April 15, 2016 9:00:58 AM

Post# of 372
Script Numbers 8-K, April 15:
http://investor.relypsa.com/sec.cfm

The 8-K goes over the end of month scripts. I had to reformat from the 8-K, hopefully that kept it clear.

March 1-31, 2016
In the outpatient setting:

• 1,277 new patients started taking Veltassa with a free-starter supply.
• 706 outpatient prescriptions were covered by payers and dispensed (retail TRx).

In the hospital/institution setting:
• 201 units were sold to hospitals and other institutions (non-retail).



Overall Quarterly Numbers

Outpatient setting

New patients who started taking Veltassa with a free starter-supply
Jan: 409 (average 102 patients/week)
Feb: 812 (average 203 patients/week)
Mar: 1,277 (average 290 patients/week)
Q1 : 2,498

Outpatient prescriptions covered and dispensed (retail TRx)
Jan: 99 (average 25 prescriptions/week)
Feb: 350 (average 87 prescriptions/week)
Mar: 706 (average 160 prescriptions/week)
Q1 : 1,155

Hospital/institution setting
Hospital/institution units sold (non-retail)
Jan: 56 (average 14 units/week)
Feb: 117 (average 29 units/week)
Mar: 201 (average 46 units/week)
Q1 : 374